A cheminformatic toolkit for mining biomedical knowledge

Pharmaceutical Research

Volumn 24, Issue 10, 2007, Pages 1791-1802

  Rosania, Gus R ^a   Crippen, Gordon ^a   Woolf, Peter ^a   States, David ^b   Shedden, Kerby ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bioactivity fingerprints; Bioinformatics; Chemical genetics; Chemical genomics; Chemical space; Cheminformatics; Data mining; High throughput screening; Mathematical modeling; QSAR

Indexed keywords

CHEMICAL AGENT;

BIOINFORMATICS; CHEMICAL GENETICS; CHEMICAL STRUCTURE; DATA BASE; DRUG ACTIVITY; GENOMICS; INFORMATION TECHNOLOGY; INTERNET; MEDICAL TECHNOLOGY; METABOLOMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEOMICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SCIENTIFIC LITERATURE; TRANSCRIPTOMICS;

ANIMALS; BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; COMPUTER GRAPHICS; COMPUTER SIMULATION; DATABASE MANAGEMENT SYSTEMS; DATABASES AS TOPIC; DRUG DESIGN; GENOMICS; HUMANS; INTERNET; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHENOTYPE; PROTEOMICS; PUBMED; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SYSTEMS INTEGRATION;

EID: 34548558833     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9285-5     Document Type: Review

References (207)

1. B. K. Wagner, S. J. Haggarty, and P. A. Clemons. Chemical genomics: probing protein function using small molecules. Am. J. Pharmacogenomics. 4:313-320 (2004).
2. R. A. Butcher and S. L. Schreiber. Using genome-wide transcriptional profiling to elucidate small-molecule mechanism. Curr. Opin. Chem. Biol. 9:25-30 (2005).
3. H. S. Moon, E. M. Jacobson, S. M. Khersonsky, M. R. Luzung, D. P. Walsh, W. Xiong, J. W. Lee, P. B. Parikh, J. C. Lam, T. W. Kang, G. R. Rosania, A. F. Schier, and Y. T. Chang. A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 124:11608-11609 (2002).
4. B. R. Stockwell. Exploring biology with small organic molecules. Nature 432:846-854 (2004).
5. G. R. Rosania, J. Merlie, Jr., N. Gray, Y. T. Chang, P. G. Schultz, and R. Heald. A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts. Proc. Natl. Acad. Sci. U. S. A. 96:4797-4802 (1999).
6. G. R. Rosania, Y. T. Chang, O. Perez, D. Sutherlin, H. Dong, D. J. Lockhart, and P. G. Schultz. Myoseverin, a microtubule-binding molecule with novel cellular effects. Nat. Biotechnol. 18:304-308 (2000).
7. G. R. Rosania. Supertargeted chemistry: identifying relationships between molecular structures and their sub-cellular distribution. Curr. Top Med. Chem. 3:659-685 (2003).
8. O. D. Perez, Y. T. Chang, G. Rosania, D. Sutherlin, and P. G. Schultz. Inhibition and reversal of myogenic differentiation by purine-based microtubule assembly inhibitors. Chem. Biol. 9:475-483 (2002).
9. Y. T. Chang, S. M. Wignall, G. R. Rosania, N. S. Gray, S. R. Hanson, A. I. Su, J. Merlie, Jr., H. S. Moon, S. B. Sangankar, O. Perez, R. Heald, and P. G. Schultz. Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors. J. Med. Chem. 44:4497-4500 (2001).
10. Y. T. Chang, N. S. Gray, G. R. Rosania, D. P. Sutherlin, S. Kwon, T. C. Norman, R. Sarohia, M. Leost, L. Meijer, and P. G. Schultz. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem. Biol. 6:361-375 (1999).
11. I. Smukste and B. R. Stockwell. Advances in chemical genetics. Annu. Rev. Genomics. Hum. Genet. 6:261-286 (2005).
12. S. L. Schreiber, K. C. Nicolaou, and K. Davies. Diversity-oriented organic synthesis and proteomics. New frontiers for chemistry & biology. Chem. Biol. 9:1-2 (2002).
13. Y. K. Kim, M. A. Arai, T. Arai, J. O. Lamenzo, E. F. Dean, 3rd, N. Patterson, P. A. Clemons, and S. L. Schreiber. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J. Am. Chem. Soc. 126:14740-14745 (2004).
14. J. Klekota, E. Brauner, F. P. Roth, and S. L. Schreiber. Using high-throughput screening data to discriminate compounds with single-target effects from those with side effects. J. Chem. Inf. Model 46:1549-1562 (2006).
15. C. P. Austin. The completed human genome: implications for chemical biology. Curr. Opin. Chem. Biol. 7:511-515 (2003).
16. A. Ramanathan, C. Wang, and S. L. Schreiber. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. U. S. A. 102:5992-5997 (2005).
17. K. Dettmer, P. A. Aronov, and B. D. Hammock. Mass spectrometry-based metabolomics. Mass. Spectrom. Rev. 26(1):51-78 (2007).
18. K. Hollywood, D. R. Brison, and R. Goodacre. Metabolomics: current technologies and future trends. Proteomics 6:4716-4723 (2006).
19. N. Schauer and A. R. Fernie. Plant metabolomics: towards biological function and mechanism. Trends Plant Sci. 11:508-516 (2006).
20. O. Ebenhoh, T. Handorf, and R. Heinrich. Structural analysis of expanding metabolic networks. Genome. Inform. Ser. Workshop Genome. Inform. 15:35-45 (2004).
21. S. Goto, T. Nishioka, and M. Kanehisa. LIGAND: chemical database of enzyme reactions. Nucleic Acids Res. 28:380-382 (2000).
22. S. Goto, Y. Okuno, M. Hattori, T. Nishioka, and M. Kanehisa. LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res. 30:402-404 (2002).
23. D. C. McShan, M. Updadhayaya, and I. Shah. Symbolic inference of xenobiotic metabolism. Pac. Symp. Biocomput. 545-556 (2004).
24. M. Reitz, A. Homeyer, and J. Gasteiger. Query generation to search for inhibitors of enzymatic reactions. J. Chem. Inf. Model 46:2333-2341 (2006).
25. E. Selkov, Jr., Y. Grechkin, N. Mikhailova, and E. Selkov. MPW: the Metabolic Pathways Database. Nucleic Acids Res. 26:43-45 (1998).
26. J. Liu, X. Wu, B. Mitchell, C. Kintner, S. Ding, and P. G. Schultz. A Small-Molecule Agonist of the Wnt Signaling Pathway. Angew Chem. Int. Ed. Engl. 44(13): 1987-1990 (2005).
27. J. S. Melnick, J. Janes, S. Kim, J. Y. Chang, D. G. Sipes, D. Gunderson, L. Jarnes, J. T. Matzen, M. E. Garcia, T. L. Hood, R. Beigi, G. Xia, R. A. Harig, H. Asatryan, S. F. Yan, Y. Zhou, X. J. Gu, A. Saadat, V. Zhou, F. J. King, C. M. Shaw, A. I. Su, R. Downs, N. S. Gray, P. G. Schultz, M. Warmuth, and J. S. Caldwell. An efficient rapid system for profiling the cellular activities of molecular libraries. Proc. Natl. Acad. Sci. U. S. A. 103:3153-3158 (2006).
28. M. Warashina, K. H. Min, T. Kuwabara, A. Huynh, F. H. Gage, P. G. Schultz, and S. Ding. A synthetic small molecule that induces neuronal differentiation of adult hippocampal neural progenitor cells. Angew Chem. Int. Ed. Engl. 45:591-593 (2006).
29. E. Zerhouni. Medicine. The NIH Roadmap. Science 302:63-72 (2003).
30. http://grants1.nih.gov/grants/guide/rfa-files/RFA-RM-04-017.html. MLSCN.
31. http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-05-012.html. RFA ECCR.
32. T. I. Oprea, J. Gottfries, V. Sherbukhin, P. Svensson, and T. C. Kuhler. Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces. J. Mol. Graph. Model 18:512-524, 541 (2000).
33. P. Japertas, R. Didziapetris, and A. Petrauskas. Fragmental methods in the analysis of biological activities of diverse compound sets. Mini. Rev. Med. Chem. 3:797-808 (2003).
34. J. Bajorath. Chemoinformatics methods for systematic comparison of molecules from natural and synthetic sources and design of hybrid libraries. J. Comput. Aided. Mol. Des. 16:431-439 (2002).
35. J. M. Shin and D. H. Cho. PDB-Ligand: a ligand database based on PDB for the automated and customized classification of ligand-binding structures. Nucleic Acids Res. 33:D238-D241 (2005).
36. B. A. Tounge, L. B. Pfahler, and C. H. Reynolds. Chemical information based scaling of molecular descriptors: a universal chemical scale for library design and analysis. J. Chem. Inf. Comput. Sci. 42:879-884 (2002).
37. A. Tropsha and W. Zheng. Rational principles of compound selection for combinatorial library design. Comb. Chem. High. Throughput. Screen 5:111-123 (2002).
38. P. Willett. Chemoinformatics-similarity and diversity in chemical libraries. Curr. Opin. Biotechnol. 11:85-88 (2000).
39. C. H. Reynolds, A. Tropsha, L. B. Pfahler, R. Druker, S. Chakravorty, G. Ethiraj, and W. Zheng. Diversity and coverage of structural sublibraries selected using the SAGE and SCA algorithms. J. Chem. Inf. Comput. Sci. 41:1470-1477 (2001).
40. M. Alvarez, R. Robey, V. Sandor, K. Nishiyama, Y. Matsumoto, K. Paull, S. Bates, and T. Fojo. Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles. Mol. Pharmacol. 54:802-814 (1998).
41. S. A. Amundson, T. G. Myers, D. Scudiero, S. Kitada, J. C. Reed, and A. J. Fornace, Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 60:6101-6110 (2000).
42. S. Tavelin, J. Taipalensuu, L. Soderberg, R. Morrison, S. Chong, and P. Artursson. Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharm. Res. 20:397-405 (2003).
43. W. J. Egan and G. Lauri. Prediction of intestinal permeability. Adv. Drug Deliv. Rev. 54:273-289 (2002).
44. R. Huang, A. Wallqvist, and D. G. Covell. Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen. Genomics 87:315-328 (2006).
45. R. Huang, A. Wallqvist, N. Thanki, and D. G. Covell. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action. Pharmacogenomics J. 5:381-399 (2005).
46. A. D. Koutsoukos, L. V. Rubinstein, D. Faraggi, R. M. Simon, S. Kalyandrug, J. N. Weinstein, K. W. Kohn, and K. D. Paull. Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action. Stat. Med. 13:719-730 (1994).
47. J. N. Weinstein, T. G. Myers, P. M. O'Connor, S. H. Friend, A. J. Fornace, Jr., K. W. Kohn, T. Fojo, S. E. Bates, L. V. Rubinstein, N. L. Anderson, J. K. Buolamwini, W. W. van Osdol, A. P. Monks, D. A. Scudiero, E. A. Sausville, D. W. Zaharevitz, B. Bunow, V. N. Viswanadhan, G. S. Johnson, R. E. Wittes, and K. D. Paull. An information-intensive approach to the molecular pharmacology of cancer. Science 275:343-349 (1997).
48. http://pubchem.ncbi.nlm.nih.gov. PubChem.
49. H. Shatkay and R. Feldman. Mining the biomedical literature in the genomic era: an overview. J. Comput. Biol. 10:821-855 (2003).
50. R. Guha, M. T. Howard, G. R. Hutchison, P. Murray-Rust, H. Rzepa, C. Steinbeck, J. Wegner, and E. L. Willighagen. The Blue Obelisk-interoperability in chemical informatics. J. Chem. Inf. Model 46:991-998 (2006).
51. D. S. Wishart, C. Knox, A. C. Guo, S. Shrivastava, M. Hassanali, P. Stothard, Z. Chang, and J. Woolsey. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34:D668-D672 (2006).
52. T. I. Oprea, I. Zamora, and A. L. Ungell. Pharmacokinetically based mapping device for chemical space navigation. J. Comb. Chem. 4:258-266 (2002).
53. T. I. Oprea and J. Gottfries. Chemography: the art of navigating in chemical space. J. Comb. Chem. 3:157-166 (2001).
54. N. P. Savchuk, K. V. Balakin, and S. E. Tkachenko. Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr. Opin. Chem. Biol. 8:412-417 (2004).
55. R. D. Cramer, R. J. Jilek, and K. M. Andrews. Dbtop: topomer similarity searching of conventional structure databases. J. Mol. Graph. Model 20:447-462 (2002).
56. C. Merlot, D. Domine, and D. J. Church. Fragment analysis in small molecule discovery. Curr. Opin. Drug Discov. Devel. 5:391-399 (2002).
57. O. Keskin, I. Bahar, R. L. Jernigan, J. A. Beutler, R. H. Shoemaker, E. A. Sausville, and D. G. Covell. Characterization of anticancer agents by their growth inhibitory activity and relationships to mechanism of action and structure. Anticancer Drug Des. 15:79-98 (2000).
58. W. G. Rice, J. A. Turpin, C. A. Schaeffer, L. Graham, D. Clanton, R. W. Buckheit, Jr., D. Zaharevitz, M. F. Summers, A. Wallqvist, and D. G. Covell. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. J. Med. Chem. 39:3606-3616 (1996).
59. A. Wallqvist, R. Huang, N. Thanki, and D. G. Covell. Evaluating chemical structure similarity as an indicator of cellular growth inhibition. J. Chem. Inf. Model 46:430-437 (2006).
60. G. Cianchetta, Y. Li, J. Kang, D. Rampe, A. Fravolini, G. Cruciani, and R. J. Vaz. Predictive models for hERG potassium channel blockers. Bioorg. Med. Chem. Lett. 15:3637-3642 (2005).
61. G. Cianchetta, R. W. Singleton, M. Zhang, M. Wildgoose, D. Giesing, A. Fravolini, G. Cruciani, and R. J. Vaz. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. J. Med. Chem. 48:2927-2935 (2005).
62. P. de Cerqueira Lima, A. Golbraikh, S. Oloff, Y. Xiao, and A. Tropsha. Combinatorial QSAR modeling of P-glycoprotein substrates. J. Chem. Inf. Model 46:1245-1254 (2006).
63. C. Hansch, A. Leo, and D. H. Hoekman. Exploring QSAR, American Chemical Society, Washington, DC, 1995.
64. T. J. Hou, W. Zhang, K. Xia, X. B. Qiao, and X. J. Xu. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties. J. Chem. Inf. Comput. Sci. 44:1585-1600 (2004).
65. S. Oloff, R. B. Mailman, and A. Tropsha. Application of validated QSAR models of D1 dopaminergic antagonists for database mining. J. Med. Chem. 48:7322-7332 (2005).
66. C. M. Breneman, C. M. Sundling, N. Sukumar, L. Shen, W. P. Katt, and M. J. Embrechts. New developments in PEST shape/property hybrid descriptors. J. Comput. Aided Mol. Des. 17:231-240 (2003).
67. J. R. Votano, M. Parham, L. M. Hall, L. H. Hall, L. B. Kier, S. Oloff, and A. Tropsha. QSAR Modeling of Human Serum Protein Binding with Several Modeling Techniques Utilizing Structure-Information Representation. J. Med. Chem. 49:7169-7181 (2006).
68. A. Golbraikh, M. Shen, Z. Xiao, Y. D. Xiao, K. H. Lee, and A. Tropsha. Rational selection of training and test sets for the development of validated QSAR models. J. Comput. Aided Mol. Des. 17:241-253 (2003).
69. S. Oloff, S. Zhang, N. Sukumar, C. Breneman, and A. Tropsha. Chemometric analysis of ligand receptor complementarity: identifying Complementary Ligands Based on Receptor Information (CoLiBRI). J. Chem. Inf. Model. 46:844-851 (2006).
70. R. Guha, J. R. Serra, and P. C. Jurs. Generation of QSAR sets with a self-organizing map. J. Mol. Graph. Model 23:1-14 (2004).
71. R. Guha and P. C. Jurs. Interpreting computational neural network QSAR models: a measure of descriptor importance. J. Chem. Inf. Model 45:800-806 (2005).
72. R. Guha and P. C. Jurs. Determining the validity of a QSAR model-a classification approach. J. Chem. Inf. Model 45:65-73 (2005).
73. A. Kurup. C-QSAR: a database of 18,000 QSARs and associated biological and physical data. J. Comput. Aided Mol. Des. 17:187-196 (2003).
74. U. Scherf, D. T. Ross, M. Waltham, L. H. Smith, J. K. Lee, L. Tanabe, K. W. Kohn, W. C. Reinhold, T. G. Myers, D. T. Andrews, D. A. Scudiero, M. B. Eisen, E. A. Sausville, Y. Pommier, D. Botstein, P. O. Brown, and J. N. Weinstein. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:236-244 (2000).
75. K. Shedden and G. R. Rosania. Exploratory chemoinformatic analysis of cell type-selective anticancer drug targeting. Mol. Pharm. 1:267-280 (2004).
76. J. E. Staunton, D. K. Slonim, H. A. Coller, P. Tamayo, M. J. Angelo, J. Park, U. Scherf, J. K. Lee, W. O. Reinhold, J. N. Weinstein, J. P. Mesirov, E. S. Lander, and T. R. Golub. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. U. S. A. 98:10787-92 (2001).
77. A. Wallqvist, A. A. Rabow, R. H. Shoemaker, E. A. Sausville, and D. G. Covell. Establishing connections between microarray expression data and chemotherapeutic cancer pharmacology. Mol. Cancer Ther. 1:311-320 (2002).
78. A. Wallqvist, A. A. Rabow, R. H. Shoemaker, E. A. Sausville, and D. G. Covell. Linking the growth inhibition response from the National Cancer Institute's anticancer screen to gene expression levels and other molecular target data. Bioinformatics 19:2212-2224 (2003).
79. D. G. Covell, A. Wallqvist, R. Huang, N. Thanki, A. A. Rabow, and X. J. Lu. Linking tumor cell cytotoxicity to mechanism of drug action: an integrated analysis of gene expression, small-molecule screening and structural databases. Proteins 59:403-433 (2005).
80. M. Monga and E. A. Sausville. Developmental therapeutics program at the NCI: molecular target and drug discovery process. Leukemia 16:520-526 (2002).
81. K. Shedden, J. Brumer, Y. T. Chang, and G. R. Rosania. Chemoinformatic analysis of a supertargeted combinatorial library of styryl molecules. J. Chem. Inf. Comput. Sci. 43:2068-2080 (2003).
82. P. J. Artymiuk, P. A. Bath, H. M. Grindley, C. A. Pepperrell, A. R. Poirrette, D. W. Rice, D. A. Thorner, D. J. Wild, P. Willett, F. H. Allen, et al. Similarity searching in databases of three-dimensional molecules and macromolecules. J. Chem. Inf. Comput. Sci. 32:617-630 (1992).
83. M. Bradley, W. Richardson, and G. M. Crippen. Deducing molecular similarity using Voronoi binding sites. J. Chem. Inf. Comput. Sci. 33:750-755 (1993).
84. R. Bruschweiler. Efficient RMSD measures for the comparison of two molecular ensembles. Root-mean-square deviation. Proteins 50:26-34 (2003).
85. G. Cruciani, M. Pastor, and R. Mannhold. Suitability of molecular descriptors for database mining. A comparative analysis. J. Med. Chem. 45:2685-2694 (2002).
86. G. M. Maggiora and V. Shanmugasundaram. Molecular similarity measures. Methods Mol. Biol. 275:1-50 (2004).
87. P. Willett. Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11:1046-1053 (2006).
88. P. Willett. Searching techniques for databases of two- and three-dimensional chemical structures. J. Med. Chem. 48:4183-4199 (2005).
89. P. Willett. Similarity-based approaches to virtual screening. Biochem. Soc. Trans. 31:603-606 (2003).
90. A. Schuffenhauer, V. J. Gillet, and P. Willett. Similarity searching in files of three-dimensional chemical structures: analysis of the BIOSTER database using two-dimensional fingerprints and molecular field descriptors. J. Chem. Inf. Comput. Sci. 40:295-307 (2000).
91. N. J. Richmond, P. Willett, and R. D. Clark. Alignment of three-dimensional molecules using an image recognition algorithm. J. Mol. Graph. Model 23:199-209 (2004).
92. N. J. Richmond, C. A. Abrams, P. R. Wolohan, E. Abrahamian, P. Willett, and R. D. Clark. GALAHAD: 1. Pharmacophore identification by hypermolecular alignment of ligands in 3D. J. Comput. Aided Mol. Des. 20:567-587 (2006).
93. J. W. Raymond, C. J. Blankley, and P. Willett. Comparison of chemical clustering methods using graph- and fingerprint-based similarity measures. J. Mol. Graph. Model 21:421-433 (2003).
94. N. E. Jewell, D. B. Turner, P. Willett, and G. J. Sexton. Automatic generation of alignments for 3D QSAR analyses. J. Mol. Graph. Model 20:111-121 (2001).
95. S. J. Edgar, J. D. Holliday, and P. Willett. Effectiveness of retrieval in similarity searches of chemical databases: a review of performance measures. J. Mol. Graph. Model 18:343-357 (2000).
96. W. Deng, C. Breneman, and M. J. Embrechts. Predicting protein-ligand binding affinities using novel geometrical descriptors and machine-learning methods. J. Chem. Inf. Comput. Sci. 44:699-703 (2004).
97. A. K. Ghose and G. M. Crippen. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC. Mol. Pharmacol. 37:725-734 (1990).
98. L. Boulu and G. M. Crippen. Voronoi receptor site models. Prog. Clin. Biol. Res. 289:267-277 (1989).
99. A. S. Smellie, G. M. Crippen, and W. G. Richards. Fast drug-receptor mapping by site-directed distances: a novel method of predicting new pharmacological leads. J. Chem. Inf. Comput. Sci. 31:386-392 (1991).
100. C. A. Parks, G. M. Crippen, and J. G. Topliss. The measurement of molecular diversity by receptor site interaction simulation. J. Comput. Aided Mol. Des. 12:441-449 (1998).
101. L. Hodes, K. Paull, A. Koutsoukos, and L. Rubinstein. Exploratory data analytic techniques to evaluate anticancer agents screened in a cell culture panel. J. Biopharm. Stat. 2:31-48 (1992).
102. Y. Tian, R. C. McEachin, C. Santos, D. J. States, and J. M. Patel. SAGA: a subgraph matching tool for biological graphs. Bioinformatics 23(2):232-239 (2007).
103. M. Kawakami, K. Koya, T. Ukai, N. Tatsuta, A. Ikegawa, K. Ogawa, T. Shishido, and L. B. Chen. Synthesis and evaluation of novel rhodacyanine dyes that exhibit antitumor activity. J. Med. Chem. 40:3151-3160 (1997).
104. Y. Huang, P. Anderle, K. J. Bussey, C. Barbacioru, U. Shankavaram, Z. Dai, W. C. Reinhold, A. Papp, J. N. Weinstein, and W. Sadee. Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 64:4294-4301 (2004).
105. T. J. Mitchison. Small-molecule screening and profiling by using automated microscopy. Chembiochem 6:33-39 (2005).
106. Z. E. Perlman, M. D. Slack, Y. Feng, T. J. Mitchison, L. F. Wu, and S. J. Altschuler. Multidimensional drug profiling by automated microscopy. Science 306:1194-1198 (2004).
107. J. N. Weinstein. Integromic Analysis of the NCI-60 Cancer Cell Lines. Breast Dis. 19:11-22 (2004).
108. T. Yamori. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics. Cancer Chemother. Pharmacol. 52(Suppl 1):S74-S79 (2003).
109. S. Ekins, Y. Nikolsky, A. Bugrim, E. Kirillov, and T. Nikolskaya. Pathway mapping tools for analysis of high content data. Methods Mol. Biol. 356:319-350 (2007).
110. A. Rzhetsky, T. Koike, S. Kalachikov, S. M. Gomez, M. Krauthammer, S. H. Kaplan, P. Kra, J. J. Russo, and C. Friedman. A knowledge model for analysis and simulation of regulatory networks. Bioinformatics 16:1120-1128 (2000).
111. A. J. Hartemink, D. K. Gifford, T. S. Jaakkola, and R. A. Young. Using graphical models and genomic expression data to statistically validate models of genetic regulatory networks. Pac. Symp. Biocomput. 422-433 (2001).
112. S. Imoto, T. Goto, and S. Miyano. Estimation of genetic networks and functional structures between genes by using Bayesian networks and nonparametric regression. Pac. Symp. Biocomput. 175-186 (2002).
113. S. Imoto, T. Higuchi, T. Goto, K. Tashiro, S. Kuhara, and S. Miyano. Combining microarrays and biological knowledge for estimating gene networks via bayesian networks. J. Bioinform. Comput. Biol. 2:77-98 (2004).
114. K. Sachs, D. Gifford, T. Jaakkola, P. Sorger, and D. A. Lauffenburger. Bayesian network approach to cell signaling pathway modeling. Sci. STKE 2002:PE38 (2002).
115. P. J. Woolf, W. Prudhomme, L. Daheron, G. Q. Daley, and D. A. Lauffenburger. Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics 21(6):741-753 (2005).
116. Y. Xia, H. Yu, R. Jansen, M. Seringhaus, S. Baxter, D. Greenbaum, H. Zhao, and M. Gerstein. Analyzing cellular biochemistry in terms of molecular networks. Annu. Rev. Biochem. 73:1051-1087 (2004).
117. X. Zhang, K. Shedden, and G. R. Rosania. A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. Mol. Pharm. 3:704-716 (2006).
118. V. Tantishaiyakul. Prediction of Caco-2 cell permeability using partial least squares multivariate analysis. Pharmazie 56:407-411 (2001).
119. H. H. Refsgaard, B. F. Jensen, P. B. Brockhoff, S. B. Padkjaer, M. Guldbrandt, and M. S. Christensen. In silico prediction of membrane permeability from calculated molecular parameters. J. Med. Chem. 48:805-811 (2005).
120. J. T. Penniston, L. Beckett, D. L. Bentley, and C. Hansch. Passive permeation of organic compounds through biological tissue: a non-steady-state theory. Mol. Pharmacol. 5:333-341 (1969).
121. K. Palm, K. Luthman, J. Ros, J. Grasjo, and P. Artursson. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. 291:435-443 (1999).
122. D. A. Norris, G. D. Leesman, P. J. Sinko, and G. M. Grass. Development of predictive pharmacokinetic simulation models for drug discovery. J. Control. Release 65:55-62 (2000).
123. Y. Marrero Ponce, M. A. Cabrera Perez, V. Romero Zaldivar, H. Gonzalez Diaz, and F. Torrens. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. J. Pharm. Pharm. Sci. 7:186-199 (2004).
124. S. Fujiwara, F. Yamashita, and M. Hashida. Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. Int. J. Pharm. 237:95-105 (2002).
125. G. Camenisch, J. Alsenz, H. van de Waterbeemd, and G. Folkers. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6:317-324 (1998).
126. S. Trapp and R. W. Horobin. A predictive model for the selective accumulation of chemicals in tumor cells. European Biophysics Journal With Biophysics Letters 34:959-966 (2005).
127. S. Trapp. Plant uptake and transport models for neutral and ionic chemicals. Environ. Sci. Pollut. Res. 11:33-39 (2004).
128. M. E. Andersen. Toxicokinetic modeling and its applications in chemical risk assessment. Toxicol. Lett. 138:9-27 (2003).
129. G. R. Rosania. Mitochondria give cells a tan. Chem. Biol. 12:412-413 (2005).
130. D. Williams, D. W. Jung, S. M. Khersonsky, N. Heidary, Y. T. Chang, and S. J. Orlow. Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism. Chem. Biol. 11:1251-1259 (2004).
131. D. W. Jung, D. Williams, S. M. Khersonsky, T. W. Kang, N. Heidary, Y. T. Chang, and S. J. Orlow. Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol. Biosyst. 1:85-92 (2005).
132. J. R. Snyder, A. Hall, L. Ni-Komatsu, S. M. Khersonsky, Y. T. Chang, and S. J. Orlow. Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. Chem. Biol. 12:477-484 (2005).
133. V. R. Fantin and P. Leder. F16, a mitochondriotoxic compound, triggers apoptosis or necrosis depending on the genetic background of the target carcinoma cell. Cancer Res. 64:329-336 (2004).
134. V. R. Fantin, M. J. Berardi, L. Scorrano, S. J. Korsmeyer, and P. Leder. A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. Cancer Cell 2:29-42 (2002).
135. J. S. Modica-Napolitano and J. R. Aprille. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv. Drug Deliv. Rev. 49:63-70 (2001).
136. A. Manetta, G. Gamboa, A. Nasseri, Y. D. Podnos, D. Emma, G. Dorion, L. Rawlings, P. M. Carpenter, A. Bustamante, J. Patel, and D. Rideout. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Gynecol. Oncol. 60:203-212 (1996).
137. T. J. Lampidis, S. D. Bernal, I. C. Summerhayes, and L. B. Chen. Selective toxicity of rhodamine 123 in carcinoma cells in vitro. Cancer Res. 43:716-720 (1983).
138. P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 92:1042-1053 (2000).
139. Q. Li, Y. Kim, J. Namm, A. Kulkarni, G. R. Rosania, Y. H. Ahn, and Y. T. Chang. RNA-selective, live cell imaging probes for studying nuclear structure and function. Chem. Biol. 13:615-623 (2006).
140. F. Rashid, R. W. Horobin, and M. A. Williams. Predicting the behaviour and selectivity of fluorescent probes for lysosomes and related structures by means of structure-activity models. Histochem. J. 23:450-459 (1991).
141. F. Rashid and R. W. Horobin. Accumulation of fluorescent non-cationic probes in mitochondria of cultured cells: observations, a proposed mechanism, and some implications. J. Microsc. 163(Pt 2):233-241 (1991).
142. F. Rashid and R. W. Horobin. Interaction of molecular probes with living cells and tissues. Part 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches. Histochemistry 94:303-308 (1990).
143. R. W. Horobinand F. Rashid. Interactions of molecular probes with living cells and tissues. Part 1. Some general mechanistic proposals, making use of a simplistic Chinese box model. Histochemistry 94:205-209 (1990).
144. R. W. Horobin. Structure-staining relationships in histochemistry and biological staining. I. Theoretical background and a general account of correlation of histochemical staining with the chemical structure of the reagents used. J. Microsc. 119:345-355 (1980).
145. J. Colston, R. W. Horobin, F. Rashid-Doubell, J. Pediani, and K. K. Johal. Why fluorescent probes for endoplasmic reticulum are selective: an experimental and QSAR-modelling study. Biotech. Histochem. 78:323-332 (2003).
146. E. Walter, S. Janich, B. J. Roessler, J. M. Hilfinger, and G. L. Amidon. HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J. Pharm. Sci. 85:1070-1076 (1996).
147. M. V. Varma, K. Sateesh, and R. Panchagnula. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Mol. Pharm. 2:12-21 (2005).
148. M. Sugawara, Y. Takekuma, H. Yamada, M. Kobayashi, K. Iseki, and K. Miyazaki. A general approach for the prediction of the intestinal absorption of drugs: regression analysis using the physicochemical properties and drug-membrane electrostatic interaction. J. Pharm. Sci. 87:960-966 (1998).
149. A. Malkia, L. Murtomaki, A. Urtti, and K. Kontturi. Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. Eur. J. Pharm. Sci. 23:13-47 (2004).
150. M. Duvvuri, W. Feng, A. Mathis, and J. P. Krise. A cell fractionation approach for the quantitative analysis of subcellular drug disposition. Pharm. Res. 21:26-32 (2004).
151. Y. Gong, M. Duvvuri, and J. P. Krise. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60. J. Biol. Chem. 278:50234-50239 (2003).
152. Y. Lai, C. M. Tse, and J. D. Unadkat. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J. Biol. Chem. 279:4490-4497 (2004).
153. R. Lill and G. Kispal. Mitochondrial ABC transporters. Res. Microbiol. 152:331-340 (2001).
154. L. M. Mangravite, I. Badagnani, and K. M. Giacomini. Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur. J. Pharmacol. 479:269-281 (2003).
155. G. Szakacs, J. P. Annereau, S. Lababidi, U. Shankavaram, A. Arciello, K. J. Bussey, W. Reinhold, Y. Guo, G. D. Kruh, M. Reimers, J. N. Weinstein, and M. M. Gottesman. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell 6:129-137 (2004).
156. V. Y. Chen and G. R. Rosania. The great multidrug-resistance paradox. ACS Chem. Biol. 1:271-273 (2006).
157. V. Y. Chen, M. M. Posada, L. L. Blazer, T. Zhao, and G. R. Rosania. The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug. Pharm. Res. 23:1687-1695 (2006).
158. Q. Li, Y. K. Kim, J. Namm, A. Kulkarni, G. Rosania, Y. H. Ahn, and Y. T. Chang. RNA-selective, live cell imaging probes for studying nuclear structure and function. Chem. Biol. in press. (2006).
159. V. Y. Chen, S. M. Khersonsky, K. Shedden, Y. T. Chang, and G. R. Rosania. System dynamics of subcellular transport. Mol. Pharm. 1:414-425 (2004).
160. A. R. Aronson. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proc. AMIA Symp. 17-21 (2001).
161. H. Hermjakob, L. Montecchi-Palazzi, C. Lewington, S. Mudali, S. Kerrien, S. Orchard, M. Vingron, B. Roechert, P. Roepstorff, A. Valencia, H. Margalit, J. Armstrong, A. Bairoch, G. Cesareni, D. Sherman, and R. Apweiler. IntAct: an open source molecular interaction database. Nucleic Acids Res. 32:D452-D455 (2004).
162. P. Ibison, M. Jacquot, F. Kam, A. G. Neville, R. W. Simpson, C. Tonnelier, T. Venczel, and A. P. Johnson. Chemical Literature Data Extraction: The CLiDE Project. J. Chem. Inf. Comput. Sci. 33:338-344 (1993).
163. R. N. Kostoff and R. A. DeMarco. Extracting information from the literature by text mining. Anal. Chem. 73:370A-378A (2001).
164. M. Krauthammer, P. Kra, I. Iossifov, S. M. Gomez, G. Hripcsak, V. Hatzivassiloglou, C. Friedman, and A. Rzhetsky. Of truth and pathways: chasing bits of information through myriads of articles. Bioinformatics 18(Suppl 1):S249-S257 (2002).
165. S. Raychaudhuri, J. T. Chang, P. D. Sutphin, and R. B. Altman. Associating genes with gene ontology codes using a maximum entropy analysis of biomedical literature. Genome. Res. 12:203-214 (2002).
166. T. C. Rindflesch, L. Hunter, and A. R. Aronson. Mining molecular binding terminology from biomedical text. Proc. AMIA Symp. 127-131 (1999).
167. T. C. Rindflesch, L. Tanabe, J. N. Weinstein, and L. Hunter. EDGAR: extraction of drugs, genes and relations from the biomedical literature. Pac. Symp. Biocomput. 517-528 (2000).
168. M. Weeber, H. Klein, A. R. Aronson, J. G. Mork, L. T. de Jong-van den Berg, and R. Vos. Text-based discovery in biomedicine: the architecture of the DAD-system. Proc. AMIA Symp. 903-907 (2000).
169. K. Baclawski, J. Cigna, M. M. Kokar, P. Mager, and B. Indurkhya. Knowledge representation and indexing using the unified medical language system. Pac. Symp. Biocomput. 493-504 (2000).
170. C. Santos, D. Eggle, and D. J. States. Wnt pathway curation using automated natural language processing: combining statistical methods with partial and full parse for knowledge extraction. Bioinformatics 21(8):1653-1658 (2005).
171. M. D. Yandell and W. H. Majoros. Genomics and natural language processing. Nat. Rev. Genet. 3:601-610 (2002).
172. M. Hattori, Y. Okuno, S. Goto, and M. Kanehisa. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. J. Am. Chem. Soc. 125:11853-11865 (2003).
173. W. D. Ihlenfeldt and J. Gasteiger. Beyond the hyperactive molecule: search, salvage and visualization of chemical information from the Internet. Pac. Symp. Biocomput. 384-395 (1996).
174. W. D. Ihlenfeldt and J. Gasteiger. Augmenting connectivity information by compound name parsing: automatic assignment of stereochemistry and isotope labeling. J. Chem. Inf. Comput. Sci. 35:663-674 (1995).
175. M. Reitz, O. Sacher, A. Tarkhov, D. Trumbach, and J. Gasteiger. Enabling the exploration of biochemical pathways. Org. Biomol. Chem. 2:3226-3237 (2004).
176. M. Kanehisa, S. Goto, S. Kawashima, and A. Nakaya. The KEGG databases at GenomeNet. Nucleic Acids Res. 30:42-46 (2002).
177. M. Kanehisa and S. Goto. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28:27-30 (2000).
178. J. R. McDaniel and J. R. Balmuth. Kekule: OCR-Optical chemical (structure) recognition. J. Chem. Inf. Comput. Sci. 32:373-378 (1992).
179. M. L. Contreras, C. Allendes, L. T. Alvarez, and R. Rozas. Computational perception and recognition of digitized molecular structures. J. Chem. Inf. Comput. Sci. 30:302-307 (1990).
180. R. Casey, S. Boyer, P. Healey, A. Miller, B. Oudot, and K. Zilles. Optical recognition of chemical graphics. Proceedings of the 2nd International Conference on Document Analysis and Recognition 627-631 (1993).
181. K. Shedden, L. B. Townsend, J. C. Drach, and G. R. Rosania. A rational approach to personalized anticancer therapy: chemoinformatic analysis reveals mechanistic gene-drug associations. Pharm. Res. 20:843-847 (2003).
182. G. V. Gkoutos, P. R. Kenway, and H. S. Rzepa. JChemTidy: a tool for converting chemical Web document collections to an XHTML representation. J. Chem. Inf. Comput. Sci. 41:253-258 (2001).
183. P. Srinivasan. MeSHmap: a text mining tool for MEDLINE. Proc. AMIA Symp. 642-646 (2001).
184. P. Srinivasan and T. Rindflesch. Exploring text mining from MEDLINE. Proc. AMIA Symp. 722-726 (2002).
185. R. D. Smith, L. Hu, J. A. Falkner, M. L. Benson, J. P. Nerothin, and H. A. Carlson. Exploring protein-ligand recognition with Binding MOAD. J. Mol. Graph. Model 24:414-425 (2006).
186. R. Wang, X. Fang, Y. Lu, and S. Wang. The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J. Med. Chem. 47:2977-2980 (2004).
187. R. Wang, Y. Lu, X. Fang, and S. Wang. An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J. Chem. Inf. Comput. Sci. 44:2114-2125 (2004).
188. Y. Z. Chen and C. Y. Ung. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach. J. Mol. Graph. Model 20:199-218 (2001).
189. Y. Z. Chen and D. G. Zhi. Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 43:217-226 (2001).
190. A. Lindstrom, F. Pettersson, F. Almqvist, A. Berglund, J. Kihlberg, and A. Linusson. Hierarchical PLS modeling for predicting the binding of a comprehensive set of structurally diverse protein-ligand complexes. J. Chem. Inf. Model 46:1154-1167 (2006).
191. N. Paul, E. Kellenberger, G. Bret, P. Muller, and D. Rognan. Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins 54:671-680 (2004).
192. C. P. Mpamhanga, B. Chen, I. M. McLay, and P. Willett. Knowledge-based interaction fingerprint scoring: a simple method for improving the effectiveness of fast scoring functions. J. Chem. Inf. Model 46:686-698 (2006).
193. H. Berman, K. Henrick, H. Nakamura, and J. L. Markley. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res. 35(Database issue):D301-303 (2007).
194. E. Kellenberger, P. Muller, C. Schalon, G. Bret, N. Foata, and D. Rognan. sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank. J. Chem. Inf. Model 46:717-727 (2006).
195. W. C. Byrem, S. C. Armstead, S. Kobayashi, R. G. Eckenhoff, and D. M. Eckmann. A guest molecule-host cavity fitting algorithm to mine PDB for small molecule targets. Biochim. Biophys. Acta 1764:1320-1324 (2006).
196. Z. E. Perlman, T. J. Mitchison, and T. U. Mayer. High-content screening and profiling of drug activity in an automated centrosome-duplication assay. Chembiochem. 6:145-151 (2005).
197. J. C. Yarrow, Z. E. Perlman, N. J. Westwood, and T. J. Mitchison. A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol. 4:21 (2004).
198. J. C. Yarrow, Y. Feng, Z. E. Perlman, T. Kirchhausen, and T. J. Mitchison. Phenotypic screening of small molecule libraries by high throughput cell imaging. Comb. Chem. High Throughput Screen 6:279-286 (2003).
199. J. C. Yarrow, G. Totsukawa, G. T. Charras, and T. J. Mitchison. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. Chem. Biol. 12:385-395 (2005).
200. V. C. Abraham, D. L. Taylor, and J. R. Haskins. High content screening applied to large-scale cell biology. Trends Biotechnol. 22:15-22 (2004).
201. D. L. Taylor. Past, present, and future of high content screening and the field of cellomics. Methods Mol. Biol. 356:3-18 (2007).
202. A. H. Gough and P. A. Johnston. Requirements, features, and performance of high content screening platforms. Methods Mol. Biol. 356:41-61 (2007).
203. K. A. Giuliano, J. R. Haskins, and D. L. Taylor. Advances in high content screening for drug discovery. Assay Drug Dev. Technol. 1:565-577 (2003).
204. R. T. Dunlay, W. J. Czekalski, and M. A. Collins. Overview of informatics for high content screening. Methods Mol. Biol. 356:269-280 (2007).
205. D. J. Wild and G. D. Wiggins. Challenges for chemoinformatics education in drug discovery. Drug Discov. Today 11:436-439 (2006).
206. D. J. Wild and G. D. Wiggins. Videoconferencing and other distance education techniques in chemoinformatics teaching and research at Indiana University. J. Chem. Inf. Model 46:495-502 (2006).
207. C. Steinbeck, C. Hoppe, S. Kuhn, M. Floris, R. Guha, and E. L. Willighagen. Recent developments of the chemistry development kit (CDK)-an open-source java library for chemo-and bioinformatics. Curr. Pharm. Des. 12:2111-2120 (2006).